Hiltrud B. Brauch

Hiltrud B. Brauch

Tuebingen, BW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 233 publications

A multi-ancestry genome-wide study of tamoxifen metabolism and breast cancer recurrence.

A multi-ancestry genome-wide study of tamoxifen metabolism and breast cancer recurrence.

Journal: NPJ breast cancer

Published: December 03, 2025

Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.

Author Correction: Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus.

Journal: Nature communications

Published: September 09, 2025

Exogenous Hormones, Tumor Intrinsic Subtypes, and Breast Cancer.

Exogenous Hormones, Tumor Intrinsic Subtypes, and Breast Cancer.

Journal: JAMA network open

Published: July 07, 2025

Supplementation of Tamoxifen with Low-Dose Endoxifen in Patients with Breast Cancer with Impaired Tamoxifen Metabolism (TAMENDOX): A Randomized Controlled Phase I/II Trial.

Supplementation of Tamoxifen with Low-Dose Endoxifen in Patients with Breast Cancer with Impaired Tamoxifen Metabolism (TAMENDOX): A Randomized Controlled Phase I/II Trial.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 16, 2025

Tamoxifen metabolites acting via BKCa orchestrate the dynamics of K+ and Ca2+ in breast cancer cells.

Tamoxifen metabolites acting via BKCa orchestrate the dynamics of K+ and Ca2+ in breast cancer cells.

Journal: The Journal of biological chemistry

Published: January 26, 2025

Polygenic score distribution differences across European ancestry populations: implications for breast cancer risk prediction.

Polygenic score distribution differences across European ancestry populations: implications for breast cancer risk prediction.

Journal: Breast cancer research : BCR

Published: August 12, 2024

Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancer.

Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancer.

Journal: NPJ breast cancer

Published: July 24, 2024

Differences in polygenic score distributions in European ancestry populations: implications for breast cancer risk prediction.

Differences in polygenic score distributions in European ancestry populations: implications for breast cancer risk prediction.

Journal: medRxiv : the preprint server for health sciences

Published: February 27, 2024

Nonlinear Mixed-Effects Model of Z-Endoxifen Concentrations in Tamoxifen-Treated Patients from the CEPAM Cohort.

Nonlinear Mixed-Effects Model of Z-Endoxifen Concentrations in Tamoxifen-Treated Patients from the CEPAM Cohort.

Journal: Clinical pharmacology and therapeutics

Published: September 13, 2023

Cytokines-activated nuclear IKKα-FAT10 pathway induces breast cancer tamoxifen-resistance.

Cytokines-activated nuclear IKKα-FAT10 pathway induces breast cancer tamoxifen-resistance.

Journal: Science China. Life sciences

Published: June 05, 2023

A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry.

A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry.

Journal: Breast cancer research : BCR

Published: April 05, 2023

Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.

Association of the CHEK2 c.1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer-specific survival.

Journal: Research square

Published: February 24, 2023

Showing 1-12 of 233

Last Updated: 09/26/2026